Business
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
REDWOOD CITY, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Codexis, a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, shared new advances in RNA therapeutic manufacturing at TIDES USA 2026 at the Hynes Convention Center in Boston. Through presentations and a panel discussion, the Company highlighted how its ECO Synthesis® Manufacturing Platform is advancing the production of siRNA, now enabling stereochemical control while add
About this update from Codexis, Inc.
[{"type":"image","alt":"Codexis, Inc.","displaySize":"","headline":null,"caption":"Codexis, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":82,"url":"https://media.zenfs.com/en/globenewswire.com/5c90477a3ba9b9c378c1bbe3fd284927"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Vv_KpKJ4M.ZoLlanslV2xg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExNQ--/https://media.zenfs.com/en/globenewswire.com/5c90477a3ba9b9c378c1bbe3fd284927","width":300,"height":82},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Vv_KpKJ4M.ZoLlanslV2xg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExNQ--/https://media.zenfs.com/en/globenewswire.com/5c90477a3ba9b9c378c1bbe3fd284927","width":300,"height":82}},"lazy":false},{"type":"text","content":"REDWOOD CITY, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Codexis, a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, shared new advances in RNA therapeutic manufacturing at TIDES USA 2026 at the Hynes Convention Center in Boston. Through presentations and a panel discussion, the Company highlighted how its ECO Synthesis® Manufacturing Platform is advancing the production of siRNA, now enabling stereochemical control while addressing key industry challenges in scalability and sustainability.","length":566,"tagName":"p"},{"type":"text","content":"At the conference, Codexis presented new data demonstrating, for the first time, full-length siRNA synthesis with precise control of phosphorothioate stereochemistry using its ECO Synthesis platform. Stereochemistry—the three-dimensional arrangement of atoms within a molecule—plays an important role in how oligonucleotide therapeutics perform, influencing their efficacy and product quality.","length":393,"tagName":"p"},{"type":"text","content":"During Codexis’ expert panel, “Stereochemistry Control in RNAi Manufacturing: Signal or Noise?”, drug development leaders from Corsera Health, Arrowhead Pharmaceuticals, and Wave Life Sciences emphasized that stereochemical control is an important—and increasingly necessary—factor in advancing next-generation RNA therapeutics in order to optimize potency, and potentially enable novel dosage forms using higher concentrations of active pharmaceutical ingredient.","length":464,"tagName":"p"},{"type":"text","content":"Codexis also announced a new advancement for it...